Health Care & Life Sciences » Biotechnology | Compass Biotechnologies Inc.

Compass Biotechnologies Inc. | Income Statement

Fiscal year is February-January. All values USD Thousands.
2011
2012
2015
2016
Cost of Goods Sold (COGS) incl. D&A
78.10
60.70
-
-
Gross Income
78.10
60.70
-
-
SG&A Expense
1,340.10
835.20
43.30
179.60
EBIT
1,489.20
907.40
43.30
179.60
Unusual Expense
-
6.00
67.10
50.00
Non Operating Income/Expense
-
25.20
-
-
Pretax Income
1,489.20
876.10
110.40
229.60
Consolidated Net Income
1,489.20
876.10
110.40
229.60
Net Income
1,489.20
876.10
110.40
229.60
Net Income After Extraordinaries
1,489.20
876.10
110.40
229.60
Net Income Available to Common
1,489.20
876.10
110.40
229.60
EPS (Basic)
0.14
0.03
0.00
0.00
Basic Shares Outstanding
10,618.60
27,507.50
525,368.90
541,594.80
EPS (Diluted)
0.14
0.03
0.00
0.00
Diluted Shares Outstanding
10,618.60
27,507.50
525,368.90
541,594.80
EBITDA
1,411.10
846.70
43.30
179.60
Other Operating Expense
71.00
11.40
-
-

About Compass Biotechnologies

View Profile
Address
8904-60 Avenue NW
Edmonton Alberta T6E 6A6
Canada
Employees -
Website -
Updated 09/14/2018
Compass Biotechnologies, Inc. is a diversified holding company providing global solutions in partnership with emerging technologies, coupled with effective positioning and unique global marketing strategies. The company was founded on May 12, 2004 by Joseph Sinkule and Garth Likes and is headquartered in Edmonton, Canada. .

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.